Wernicke Encephalopathy

Download PDF

Recent Publications on Wernicke Encephalopathy:
Wernicke's encephalopathy-like lesions in global cerebral hypoxia. We report a patient with severe hypoxic encephalopathy after cardiac...	24th June, 2008	Department of Neurology, Hiratsuka Kyosai Hospital, 9-11 Oiwake, Hiratsuka	J Clin Neurosci. 2008 Mar;15(3):318-9. DOI Direct Link
MR Imaging Can Predict the Development of Nonalcoholic Wernicke Encephalopathy. Werner syndrome (WS) is an autosomal recessive progeroid syndrome caused...	21st June, 2008	Department of NeurologyKeio University School of MedicineTokyo, Japan.	AJNR Am J Neuroradiol. 2008 Jun 19;. DOI Direct Link
Metronidazole-Induced and Wernicke Encephalopathy: Two Different Entities Sharing the Same Metabolic Pathway? Werner syndrome (WS) is an autosomal recessive progeroid syndrome caused...	21st June, 2008	Department of Radiology.	AJNR Am J Neuroradiol. 2008 Jun 23;. DOI Direct Link
Atypical Wernicke's encephalopathy showing lesions in the cranial nerve nuclei and cerebellum. Wernicke's encephalopathy (WE) is a severe neurological disorder caused by...	18th June, 2008	Radiology Department, Arcispedale Santa Maria Nuova, Reggio Emilia, Italy.	J Neuroimaging. 2008 Apr;18(2):194-7. Epub 2007 Oct 18. DOI Direct Link
[Wernicke encephalopathy after subtotal gastrectomy for morbid obesity.] Wernicke's encephalopathy (WE) is one of the potential complications of...	17th June, 2008	Service d'imagerie medicale, hopital Laveran, boulevard Laveran, 13013	Rev Neurol (Paris). 2008 May;164(5):463-467. Epub 2008 Mar 26. DOI Direct Link
→View more research publications.

Wernicke Encephalopathy Clinical Trials:
Re-Enrollment Repetitive Transcranial Magnetic Stimulation Trial for Auditory Hallucinations	Schizophrenia Interventions: Device: Magstim Rapid 2 system triggering Magstim Super Rapid system;   Device: Magstim Rapid-2 system triggering Magstim Super Rapid system
Effectiveness of Transcranial Magnetic Stimulation for Reducing "Voices" in People With Schizophrenia	Schizophrenia;   Hallucinations

Wernicke Encephalopathy Patents:
US Patent No.	Title
6391589	Human chemokine beta-10 mutant polypeptides
6753164	Nucleic acids encoding human serpin polypeptide HMCIS41
6761904	Pharmaceutical kit comprising midodrine as active drug substance
6770466	Human protein tyrosine phosphatase polynucleotides, polypeptides, and antibodies
6824993	Antibodies that bind human prostate specific G-protein receptor HPRAJ70
→View more patents.

BioPortfolio Ltd. offers e-mail and postal lists for Wernicke Encephalopathy scientists - we have details of around 111 individuals working on Wernicke Encephalopathy .

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.  See User Agreement

Send comments and feedback to:
Peter Barfoot Managing Director, BioPortfolio Ltd.
UK Tel: (+44) 1300 321501
USA Voicemail and Fax: (+1) 415 680 2472

All rights reserved. All other trademarks recognized.

BioPortfolio Limited is registered in England & Wales at Wessex Barn, Dorchester Road, Frampton, Dorset, DT2 9NB, UK. No.3312883 VAT No. GB 744 6483 10

Copyright 1997-2008 - BioPortfolio Limited.